Chemotherapy Induced Neutropenia Unknown Status Phase 4 Trials for Filgrastim (DB00099)

Also known as: Neutropenia post-chemotherapy / Chemotherapy-Induced Neutropenia / Chemotherapy Associated Neutropenia / Chemotherapy-induced neutropenia (disorder) / Neutropenia, unspecified / Neutropenia / Neutropenia (disorder) [Ambiguous] / Neutropenic disorder (disorder) / (Agranulocytosis) or (Kostmann's syndrome) or (neutropenia) / Neutropenias

IndicationStatusPhase
DBCOND0051348 (Chemotherapy Induced Neutropenia)Unknown Status4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03823950Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer PatientsSupportive Care
NCT03793205G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer PatientsTreatment